Lintao Wang Selected Research

Ado-Trastuzumab Emtansine

1/2017	Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates.
1/2016	Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
9/2005	Structural characterization of the maytansinoid-monoclonal antibody immunoconjugate, huN901-DM1, by mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lintao Wang Research Topics

Disease

15	Neoplasms (Cancer) 01/2022 - 09/2005
10	Inflammation (Inflammations) 08/2023 - 09/2015
7	Wounds and Injuries (Trauma) 01/2018 - 09/2015
7	Fibrosis (Cirrhosis) 12/2017 - 09/2015
6	Obesity 12/2017 - 11/2015
4	Bites and Stings (Sting) 12/2023 - 01/2021
4	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2023 - 01/2022
3	Cardiomegaly (Heart Hypertrophy) 12/2023 - 04/2016
3	Hyperglycemia 03/2019 - 10/2015
2	Hypertrophy 12/2023 - 01/2018
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2020 - 04/2015
2	Atherosclerosis 07/2018 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 12/2017 - 04/2016
1	Neointima 08/2023
1	Brain Injuries (Brain Injury) 11/2022
1	Liver Diseases (Liver Disease) 11/2022
1	Necrosis 11/2022
1	Brain Ischemia (Cerebral Ischemia) 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Hydrocephalus (Hydrocephaly) 01/2022
1	Diarrhea 01/2021
1	Cardiotoxicity 01/2021
1	Insulinoma 03/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	Atherosclerotic Plaque (Atheroma) 07/2018
1	Fibrosarcoma 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Proteinuria 12/2017
1	Sepsis (Septicemia) 08/2017
1	Lung Injury 08/2017
1	Vascular Remodeling 01/2017
1	Silicosis 01/2017

Drug/Important Bio-Agent (IBA)

7	Immunoconjugates (Immunoconjugate)IBA 10/2019 - 09/2005
5	InterferonsIBA 12/2023 - 01/2021
4	CytokinesIBA 01/2018 - 10/2015
4	Palmitic Acid (Hexadecanoic Acid)IBA 01/2018 - 11/2015
3	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2023 - 01/2021
3	Angiotensin IIIBA 12/2023 - 04/2016
3	LipidsIBA 07/2018 - 12/2017
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2017
3	Ado-Trastuzumab EmtansineIBA 01/2017 - 09/2005
3	ErbB Receptors (EGF Receptor)IBA 01/2017 - 04/2016
2	Becaplermin (PDGF-BB)FDA Link 08/2023 - 12/2017
2	Silicon Dioxide (Silica)FDA LinkGeneric 11/2022 - 01/2017
2	C-Reactive ProteinIBA 01/2022 - 01/2022
2	Insulin (Novolin)FDA Link 03/2019 - 01/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 10/2015
2	LipopolysaccharidesIBA 12/2017 - 08/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2017 - 01/2017
2	ApolipoproteinsIBA 01/2017 - 04/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 09/2015
2	Chalcone (Benzalacetophenone)IBA 11/2015 - 10/2015
2	Maytansine (Maitansine)IBA 06/2015 - 07/2006
1	vadimezanIBA 12/2023
1	OligosaccharidesIBA 08/2023
1	Biocompatible Materials (Biomaterials)IBA 08/2023
1	AlbuminsIBA 01/2023
1	AlarminsIBA 11/2022
1	Epidermal Growth Factor (EGF)IBA 11/2022
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Environmental BiomarkersIBA 01/2022
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Antisense OligonucleotidesIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	SmectiteIBA 01/2021
1	MineralsIBA 01/2021
1	Toll-Like Receptor 2IBA 01/2021
1	ClayIBA 01/2021
1	ribosomal protein L32IBA 01/2020
1	exatecan (DX 8951f)IBA 10/2019
1	Blood Glucose (Blood Sugar)IBA 03/2019
1	Monoclonal AntibodiesIBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2018
1	AcidsIBA 07/2018
1	kaempferolIBA 01/2018
1	ChromatinIBA 01/2018
1	PlasticsIBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Staphylococcal Protein A (Protein A)IBA 01/2018
1	CreatinineIBA 12/2017
1	GelatinIBA 12/2017
1	PolymersIBA 12/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	Brentuximab VedotinIBA 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	AMP-Activated Protein KinasesIBA 01/2017
1	EndotoxinsIBA 11/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2016

Therapy/Procedure

4	Therapeutics 01/2019 - 09/2005
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2021
2	Oral Administration 01/2021 - 10/2015
1	Tissue Transplantation 11/2022
1	Immunotherapy 01/2021
1	Islets of Langerhans Transplantation 03/2019